# Trustmark Corp: overview

TRMK · Nasdaq · CIK 36146 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trmk.md) · [Financials](/companies/trmk/financials.md) · [Filings](/companies/trmk/filings.md) · [Insiders](/companies/trmk/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.84](/filings/0001193125-25-267205.md) | not reported | [0.88](/filings/0001193125-26-209195.md) | [0.92](/filings/0001193125-26-335156.md) | [0.94](/filings/0001193125-25-267205.md) | not reported | [0.95](/filings/0001193125-26-209195.md) | [1.08](/filings/0001193125-26-335156.md) |
| Free cash flow | $m | [51.2 d](/filings/0001193125-25-267205.md) | [95.3 d](/filings/0001193125-26-064009.md) | [80.6](/filings/0001193125-26-209195.md) | [34.5 d](/filings/0001193125-26-335156.md) | [62.7 d](/filings/0001193125-25-267205.md) | [54.1 d](/filings/0001193125-26-064009.md) | [20.6](/filings/0001193125-26-209195.md) | [49.5 d](/filings/0001193125-26-335156.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.34](/filings/0000950170-24-015988.md) | [1.17](/filings/0000950170-25-023184.md) | [2.70](/filings/0001193125-26-064009.md) | [3.63](/filings/0001193125-26-064009.md) | [3.70](/filings/0001193125-26-064009.md) |
| Free cash flow | $m | [321](/filings/0000950170-24-015988.md) | [270](/filings/0000950170-25-023184.md) | [157](/filings/0001193125-26-064009.md) | [93.4](/filings/0001193125-26-064009.md) | [232](/filings/0001193125-26-064009.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/trmk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $395.9m | 8,605,088 |  | Added +303,863 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $181.3m | 3,940,082 |  | Added +42,526 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $163.9m | 3,562,663 |  | Added +37,860 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $152.4m | 3,312,492 |  | Added +337,527 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $116.9m | 2,540,499 |  | Reduced −4,923 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $112.2m | 2,439,025 |  | Reduced −93,577 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $78.0m | 1,695,444 |  | Added +429,145 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $73.4m | 1,595,875 |  | Added +81,274 |
| [North Reef Capital Management LP](/funds/1867831.md) | 2026-06-30 | $72.0m | 1,565,551 |  | Reduced −387,379 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $70.4m | 1,529,504 |  | Reduced −1,764,593 |

## Recent filings

[All 1,630 filings](/companies/trmk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-10 | 07:30 ET | [8-K](/filings/0001193125-26-387233.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-387233 |
| 2026-08-05 | 16:16 ET | [10-Q](/filings/0001193125-26-335156.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335156 |
| 2026-07-28 | 16:40 ET | [8-K](/filings/0001193125-26-321132.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-321132 |
| 2026-05-19 | 16:45 ET | [8-K](/filings/0001193125-26-230967.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-230967 |
| 2026-05-06 | 16:41 ET | [10-Q](/filings/0001193125-26-209195.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209195 |
| 2026-04-29 | 16:58 ET | [8-K](/filings/0001193125-26-192135.md) | 5.07 Shareholder vote results | 0001193125-26-192135 |
| 2026-04-28 | 16:40 ET | [8-K](/filings/0001193125-26-187358.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-187358 |
| 2026-03-30 | 17:43 ET | [8-K](/filings/0001193125-26-132107.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-132107 |
| 2026-03-16 | 08:00 ET | [DEF 14A](/filings/0001193125-26-107265.md) | Proxy statement, period 2026-04-28 | 0001193125-26-107265 |
| 2026-02-23 | 16:16 ET | [10-K](/filings/0001193125-26-064009.md) | Annual report, period 2025-12-31 | 0001193125-26-064009 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-064009.md), filed Feb 23, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 36146
- Tickers: TRMK
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: MS
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:41 ET. No prices; not investment advice.